Insights: Stories
Mayo Clinic Laboratories combines the expertise of world-renowned laboratorians and physicians to provide answers for patients’ serious and complex medical challenges.
These are the stories of the people throughout that journey — from the laboratorians conducting tests and delivering results, to the physicians guiding diagnosis and treatment, to the patients worldwide who need answers.
Most recent posts
Specialized immunofluorescence testing helps uncover rare autoimmune blistering diseases, identify underlying cancers, and guide precise treatment, improving diagnostic accuracy and outcomes for patients with challenging skin disorders.
Controlled substance testing options vary in the details they provide about patient drug use, painting an incomplete picture of usage patterns that can hinder accurate prescription monitoring and treatment outcomes. However, a new comprehensive Controlled Substance Monitoring Panel, developed by the Clinical and Forensic Toxicology Laboratory at Mayo Clinic Laboratories, offers in-depth analysis on more than 70 different prescription medications and illicit substances to provide clinicians with details and interpretations on patients’ controlled substance use lacking in other laboratory assays.
This week’s research roundup features a study on the management of patients with giant cell myocarditis.
Top highlights include: The impact COVID-19 has had on women, SARS-CoV-2 mutations explained, and expert answers about the new COVID-19 vaccine.
As she heads toward retirement at the end of March, Rita Baird looks back on her career at Mayo Clinic Laboratories and discusses her role working with MCL clients as a regional service representative.
This week’s research roundup features a phase III study of lenalidomide plus R-CHOP versus placebo plus R-CHOP in previously untreated patients With ABC-type diffuse large b-cell lymphoma.
Top highlights include: a list of COVID-19 drugs and how they work, policy changes in visitor policy at Mayo Clinic in Rochester, and what to know about kids going back to school.
This week’s research roundup features a study on the sequencing of 53,831 diverse genomes from the NHLBI TOPMed program.
Top highlights include: side effects of the COVID-19 vaccine, tackling the latest pandemic topics, and World Encephalitis Day.
A supervisor in the lab that's at the heart of Mayo Clinic Laboratories' COVID-19 testing, Dave Majewski's job has changed dramatically in the last year, as he went from overseeing about 40 staff members to more than 240 in a lab that now runs 24/7.
This week’s research roundup features a study on trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.
This week’s research roundup features an expert review of the AGA clinical practice update on the management of refractory helicobacter pylori infection.
A genetic counselor with Mayo Clinic Laboratories for the last 15 years, Cassie Runke relishes her role serving as a resource for health care providers who are looking to help their patients find answers through genetic testing.